about
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pa...
Read More
2.52
0.25
(11.01%)
1.3M
XNAS Volume
XNAS 22 Aug, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..